XERIS PHARMACEUTICALS INC (CIK: 0001346302) EDGAR, Information, Filings... CompaniesBIO.Com

XERIS PHARMACEUTICALS INC

Mailing address
180 NORTH LASALLE STREET, SUITE 1600, CHICAGO, Delaware, 60601
Phone
844-445-5704
State location
Illinois
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

XERIS PHARMACEUTICALS INC (CIK: 0001346302) is an American company incorporated in the state of Illinois. Head office is located at 180 NORTH LASALLE STREET, SUITE 1600, CHICAGO, Illinois, 60601. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. XERIS PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Pieper Steven	0001875714	Jul-28-2021	officer: See Remarks
Thierer Mark	0001334925	Sep-30-2019	director
Hecht Beth	0001652410	Jan-01-2019	officer: See Remarks
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	0001009258	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
Deerfield Mgmt L.P.	0001010823	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
SHERMAN JEFFREY W	0001230482	Jun-20-2018	director
PERSKY MARLA	0001270354	Jun-20-2018	director
Deutsch Barry M.	0001289407	Jun-20-2018	officer: Chief Financial Officer
Flynn James E	0001352546	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
Deerfield Special Situations Fund, L.P.	0001354395	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
RIGBY JONATHAN	0001356227	Jun-20-2018	director
Redmile Group, LLC	0001425738	Jun-20-2018	10 percent owner
Schmid John P.	0001478916	Jun-20-2018	director
Edick Paul R	0001531178	Jun-20-2018	director, officer: See Remarks
Shannon John Patrick Jr	0001553595	Jun-20-2018	officer: See Remarks
Deerfield Private Design Fund III, L.P.	0001603333	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
Deerfield Mgmt III, L.P.	0001610540	Jun-20-2018	10 percent owner, other: Possible Member of 10% Group
BORMANN-KENNEDY BARBARA-JEAN ANNE	0001635065	Jun-20-2018	director
Green Jeremy	0001650527	Jun-20-2018	10 percent owner
HALKUFF DAWN	0001743658	Jun-20-2018	director
JOHNSON KENNETH ERLAND	0001743774	Jun-20-2018	officer: See Remarks
PRESTRELSKI STEVEN	0001744027	Jun-20-2018	officer: Chief Scientific Officer
Palmetto Partners, Ltd.	0001744226	Jun-20-2018	10 percent owner
Palmetto Partners 2014, LP	0001744227	Jun-20-2018	10 percent owner
Palmetto Partners 2015, LP	0001744228	Jun-20-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XERIS PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001398344-22-003371 (34 Act) Size: 116 KB	Feb-14-2022	005-90534 22634977
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-21-300050 (34 Act) Size: 11 KB	Oct-15-2021	001-38536 211326276
EFFECT	Document	Acc-no: 9999999995-21-003793 (33 Act) Size: 1 KB	Oct-06-2021	333-233061 211310973
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039260 ( Act) Size: 13 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039259 ( Act) Size: 13 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039257 ( Act) Size: 15 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039255 ( Act) Size: 13 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039254 ( Act) Size: 22 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039253 ( Act) Size: 20 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039249 ( Act) Size: 22 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039248 ( Act) Size: 21 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039246 ( Act) Size: 22 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039244 ( Act) Size: 13 KB	Oct-05-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-039242 ( Act) Size: 22 KB	Oct-05-2021
25-NSE	Document	Acc-no: 0001354457-21-001128 (34 Act) Size: 2 KB	Oct-05-2021	001-38536 211307450
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-21-292163 (33 Act) Size: 24 KB	Oct-05-2021	333-233061 211307216
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-292157 (33 Act) Size: 22 KB	Oct-05-2021	333-225802 211307157
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-292144 (33 Act) Size: 22 KB	Oct-05-2021	333-229587 211307060
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-292123 (33 Act) Size: 22 KB	Oct-05-2021	333-237120 211306978
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-292118 (33 Act) Size: 22 KB	Oct-05-2021	333-254044 211306939

Recent 20 filings. View all XERIS PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

XERIS PHARMACEUTICALS INC overview
XERIS PHARMACEUTICALS INC job
XERIS PHARMACEUTICALS INC stock
XERIS PHARMACEUTICALS INC ownership
XERIS PHARMACEUTICALS INC CEO
XERIS PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.